arrow
P

Premal Lulla

Texas Children's Hospital and Houston Methodist Hospital
H指数:26
被引数:2,786

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial

自体多抗原靶向T细胞疗法治疗胰腺癌:一项1/2期临床试验

2026-01-020
OAAI
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

新型合并症指数与大型B细胞淋巴瘤嵌合抗原受体T细胞治疗后生存期的关联

2025-08-180
OAAI
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
2024-12-011
OAAI
Statins May Improve Outcomes and Toxicities in Patients Undergoing CD19-Specific CAR T-Cell Therapy for Aggressive B-Cell Lymphomas

他汀类药物可能改善接受CD19特异性CAR T细胞疗法治疗侵袭性B细胞淋巴瘤患者的结局和毒副作用。

BLOOD
IF23.1
2024-11-050
PRE
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer

多抗原靶向T细胞疗法治疗复发/难治性乳腺癌

2022-07-157
OAAI
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis
2022-01-1827
OAAI
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma
2020-07-2928
PREAI